Higher Levels of Heart Disease Protein Associated with Early-Stage Brain Damage
By Andrew Deutsch Posted on 13 Dec 2016 |
Image: The structural MR imaging markers of sub-clinical brain damage (Photo courtesy of RSNA).
The results of a large-scale study have shown that blood serum levels of a cardiac wall stress protein, NT-proBNP (N-terminal Pro-B-type natriuretic peptide), are linked to brain damage as well.
The study group consisted of 2,397 middle-aged and elderly people, from a suburb in Rotterdam, the Netherlands. None of the people had dementia, or a clinical diagnosis of heart disease. Previous studies indicated a link between heart disease and brain disease, but the new study for the first time has shown the association between the NT-proBNP protein and sub-clinical brain damage, including a change in brain volume, and the in integrity of brain white matter. The study was published in the December 2016 issue of the journal Radiology.
One hypothesis for the results put forward by the researchers included the possibility that decreased blood flow could lead to cerebral microvascular damage, or create problems for the functioning of the Blood-Brain Barrier (BBB).
Lead author of the study, neuroradiologist Meike W. Vernooij, MD, PhD, Erasmus MC University Medical Center (Rotterdam, Netherlands), said, “We found that higher serum levels of NT-proBNP were associated with smaller brain volumes, in particular with smaller gray matter volume, and with poorer organization of the brain’s white matter. We cannot rule out that the observed subclinical brain damage led to increased levels of NT-proBNP. However, from a biological perspective, and based on animal studies, it is more likely that cardiac dysfunction affects brain changes rather than vice versa.”
Related Links:
Erasmus MC University Medical Center
The study group consisted of 2,397 middle-aged and elderly people, from a suburb in Rotterdam, the Netherlands. None of the people had dementia, or a clinical diagnosis of heart disease. Previous studies indicated a link between heart disease and brain disease, but the new study for the first time has shown the association between the NT-proBNP protein and sub-clinical brain damage, including a change in brain volume, and the in integrity of brain white matter. The study was published in the December 2016 issue of the journal Radiology.
One hypothesis for the results put forward by the researchers included the possibility that decreased blood flow could lead to cerebral microvascular damage, or create problems for the functioning of the Blood-Brain Barrier (BBB).
Lead author of the study, neuroradiologist Meike W. Vernooij, MD, PhD, Erasmus MC University Medical Center (Rotterdam, Netherlands), said, “We found that higher serum levels of NT-proBNP were associated with smaller brain volumes, in particular with smaller gray matter volume, and with poorer organization of the brain’s white matter. We cannot rule out that the observed subclinical brain damage led to increased levels of NT-proBNP. However, from a biological perspective, and based on animal studies, it is more likely that cardiac dysfunction affects brain changes rather than vice versa.”
Related Links:
Erasmus MC University Medical Center
Latest MRI News
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods
- DW-MRI Lights up Small Ovarian Lesions like Light Bulbs